Tectonic Therapeutic, Inc. (TECX NASDAQ) stock market data APIs
$17.1995
0.29(1.7%)
as of October 24, 2025
Try our APIs with
free plan!
Tectonic Therapeutic, Inc. Financial Data Overview
Price chart is built with
Anychart
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
Prev. Close
17.1995
Open
17.4905
High
17.9345
Low
17.2458
52 wk Range
13.7-61.07
Market Cap
321 M
P/E Ratio
4.1425
Shares Outstanding
18 712 K
EPS
-1.07
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Tectonic Therapeutic, Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Tectonic Therapeutic, Inc. data using free add-ons & libraries
Get Tectonic Therapeutic, Inc. Fundamental Data
Tectonic Therapeutic, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -72 624 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: -1.32
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tectonic Therapeutic, Inc. News
New
Tectonic Therapeutic a new outperform at Oppenheimer on heart drug asset
[Sign for Wall Street in New York City] Pharrel Wiliams * Oppenheimer has initiated coverage of Tectonic Therapeutic (NASDAQ:TECX [https://seekingalpha.com/symbol/TECX]) with an outperform rating c...
Here are the top movers in Tuesday's session.
Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis. [topmovers] TODAY'S TOP ...
Top movers analysis in the middle of the day on 2025-09-02: top gainers and losers in today's session.
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHANGE ...
There are notable gap-ups and gap-downs in today's session.
The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. [gap] TODAY'S GAP UP STOCKS ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
